Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121201122 | 12120112 | 2 | F | 20160920 | 20160226 | 20160928 | EXP | US-ASTRAZENECA-2016SE16374 | ASTRAZENECA | 47.00 | YR | F | Y | 72.60000 | KG | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121201122 | 12120112 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 10.0MG UNKNOWN | 21366 | 10 | MG | TABLET | |||||||
| 121201122 | 12120112 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | GENERIC, 40 MG ONE PILL AT NIGHT | 0 | ||||||||||
| 121201122 | 12120112 | 3 | SS | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Unknown | 20.0MG UNKNOWN | U | U | 0 | 20 | MG | ||||||
| 121201122 | 12120112 | 4 | SS | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Unknown | 20.0MG UNKNOWN | U | U | 0 | 20 | MG | ||||||
| 121201122 | 12120112 | 5 | SS | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Unknown | 40.0MG UNKNOWN | U | U | 0 | 40 | MG | TABLET | |||||
| 121201122 | 12120112 | 6 | SS | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Unknown | 40.0MG UNKNOWN | U | U | 0 | 40 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121201122 | 12120112 | 3 | Blood cholesterol increased |
| 121201122 | 12120112 | 4 | Blood triglycerides increased |
| 121201122 | 12120112 | 5 | Blood cholesterol increased |
| 121201122 | 12120112 | 6 | Blood triglycerides increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121201122 | 12120112 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121201122 | 12120112 | Abdominal distension | |
| 121201122 | 12120112 | Arthralgia | |
| 121201122 | 12120112 | Asthenia | |
| 121201122 | 12120112 | Blood cholesterol decreased | |
| 121201122 | 12120112 | Condition aggravated | |
| 121201122 | 12120112 | Drug ineffective | |
| 121201122 | 12120112 | Dry mouth | |
| 121201122 | 12120112 | Erythema | |
| 121201122 | 12120112 | Fall | |
| 121201122 | 12120112 | Hepatic enzyme increased | |
| 121201122 | 12120112 | Limb injury | |
| 121201122 | 12120112 | Lipids increased | |
| 121201122 | 12120112 | Muscle spasms | |
| 121201122 | 12120112 | Muscular weakness | |
| 121201122 | 12120112 | Musculoskeletal disorder | |
| 121201122 | 12120112 | Musculoskeletal stiffness | |
| 121201122 | 12120112 | Pain | |
| 121201122 | 12120112 | Pain in extremity | |
| 121201122 | 12120112 | Paraesthesia | |
| 121201122 | 12120112 | Rib fracture | |
| 121201122 | 12120112 | Skin discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121201122 | 12120112 | 2 | 201311 | 0 | ||
| 121201122 | 12120112 | 3 | 201403 | 0 | ||
| 121201122 | 12120112 | 4 | 201403 | 0 | ||
| 121201122 | 12120112 | 5 | 2014 | 0 | ||
| 121201122 | 12120112 | 6 | 2014 | 0 |